AstraZeneca PLC (NYSE:AZN) Short Interest Update

According to the latest stock data, investors are looking at AstraZeneca PLC (NYSE:AZN)’s short data and trying to figure out market sentiment on which way the market thinks the stock is moving. The firm has 0.35% of total shares float short, yielding a short ratio of 2.39.

After an investor has figured out their financial and investment goals, they may be interested in designing a specific stock portfolio that will serve those goals and help create and sustain profits well into the future. There is an overwhelming amount of information available on creating winning stock portfolios. Some strategies will work well for certain individuals, and some strategies will not. Understanding the challenges that are involved with creating the perfect portfolio may help the investor ascertain how much time is needed to properly manage the portfolio. Some investors will want to be hands on and do everything. Others will seek and employ the expertise of industry professionals. 

When investors engage in short selling or “shorting a stock”, they actually borrow shares from an existing owner, sell the borrowed shares at market price, and take the cash.  The short sellers then promise to replace the stock in the future and makes dividend payments out of their own pockets to cover the dividend income that is no longer exists on the original, now borrowed and sold, shares.

They hope that the stock price will fall or that the company will fail and go bankrupt, leading the equity holders to ruin.  The short sellers will then buy the stock back at a much lower price and replace the borrowed shares, pocketing the difference. 

Let’s take a look at how the stock has been performing recently.  Over the past twelve months, AstraZeneca PLC (NYSE:AZN)’s stock was 14.15%.  Over the last week of the month, it was 2.25%, 10.00% over the last quarter, and  16.16% for the past six months. 

Over the past 50 days, AstraZeneca PLC stock’s -0.61% off of the high and 14.95% removed from the low.  Their 52-Week High and Low are noted here.  -0.61% away from the high and 37.32% from the low. 

The consensus analysts recommendation at this point stands at 1.80 on AstraZeneca PLC (NYSE:AZN).  This is based on a 1-5 scale where 1 indicates a Strong Buy and 5 a Strong Sell. The same analysts are predicting that the company shares will trade to $39.89 within the next 12-18 months. 

Disclaimer: The views, opinions, and information expressed in this article are those of the authors and do not necessarily reflect the official policy or position of any company stakeholders, financial professionals, or analysts. Examples of analysis performed within this article are only examples. They should not be utilized to make stock portfolio or financial decisions as they are based only on limited and open source information. Assumptions made within the analysis are not reflective of the position of any analysts or financial professionals.